
Avenue Therapeutics Inc (ATXI)
US$ 1.944.3%
Price Chart
Key Statistics
Market Cap
$ 821.05K
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
32.33K
52W High
$ 3.93
52W Low
$ 0.17
Dividend Yield
0.00%
Beta
-0.10
Technicals
50-Day MA
0.24
200-Day MA
1.1917
52 Week High
3.9313
52 Week Low
0.1653
About ATXI
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases.
Employees
2
Headquarters
Bay Harbor Islands, FL
CEO
Dr. Alexandra MacLean M.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg